Nutrigenomics Market Research Report - Global Forecast till 2023

Nutrigenomics Market Research Report - Global Forecast till 2023

ID: MRFR/HC/2692-CRR | August, 2017 | Region: Global | 94 pages | Cooked Research Reports

Nutrigenomics market information, by products (reagents & kits, services), by techniques (saliva, buccal swab, blood, others), by applications (obesity, diabetes, anti-aging, chronic diseases) - Global forecast till 2023


Figure- Global Nutrigenomics Market, by Application 2014-2023 (USD MILLION)
Nutrigenomics Market, by Application 2014-2023


Source: Annual reports, company presentation, World Health Organization (WHO), Centers for Disease Control and Prevention, Healthline Media, American Diabetes Association, The National Institute of Diabetes and Digestive and Kidney Diseases, Asian Diabetes Prevention Initiative, The Obesity Society, company website, and MRFR Analysis


Intended Audience:



  • Nutrigenomics Products Manufacturers

  • Nutrigenomics Products Providers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology:
Research Methodology nutrigenomics market


 Source: Annual Reports, Company Presentation, World Health Organization (WHO), Centers for Disease Control and Prevention, Healthline Media, American Diabetes Association, The National Institute of Diabetes and Digestive and Kidney Diseases, Asian Diabetes Prevention Initiative, The Obesity Society, Company Website, and MRFR Analysis


Market synopsis of global nutrigenomics market:


Market Scenario:


Neutrigenomics is the study of interaction of nutrient and genes. It studies the effect of food and their constituents on the genes. The major factors contributing for the growth of the market are rising diabetic and obese population, increasing applications in dermatology, and increasing demand for the advanced diagnostic methods. According to the International Diabetes Federation (2016), 420 million adults were suffering from diabetes which is expected to reach 625 million by 2040. Further, as per the World Health Organization (2014), more than 600 million adults were obese and 1.9 billion adults, were overweight. Moreover, increasing healthcare expenditure, and government support for research & development has fueled the market growth. However, high cost of treatment and need of well qualified physicians may restrain the growth of market.


The market for nutrigenomics is growing at a tremendous pace. The market is expected to grow at the CAGR of 16.8% during the forecast period and is estimated to reach USD 17,313.5 million by 2023.


Segments:                                                                                                                                           


Global nutrigenomics market has been segmented on the basis of products, techniques and application. On the basis of products, the market is categorized into reagents & kits, services. On the basis of techniques, the market is segmented into saliva, buccal swab, blood, others. On the basis of application the market is segmented into obesity, diabetes, anti-aging, chronic diseases.


Regional analysis of global nutrigenomics market:                 


Considering the global scenario of the market, America dominates the global nutrigenomics market owing to the presence of huge population suffering from diabetes and obesity. North America holds the largest market share in America nutrigenomics market. According to the Centers for Disease Control and Prevention (2015), in America approximately 9.3% of the total America population is suffering from diabetes. Europe has the second largest market for the nutrigenomics which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the nutrigenomics market in Europe is growing at a CAGR of 17%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge diabetic and obese population and rising healthcare expenditure. Asia Pacific nutrigenomics market is expected to grow at a CAGR of 17.1% during the forecasted period. The Middle East & Africa is expected to have limited growth. Middle East is dominating this market by holding 64.3% of the Middle East & Africa market share.


Key Findings:



  • Obesity segment accounts for the largest market share in the global nutrigenomics market while diabetes segment is projected to grow at a CAGR of 17.1% during the forecast period from 2017 – 2023.

  • Reagents and kits segment accounts for the largest market share in the global nutrigenomics market by products, this segment is expected to reach USD 10,138.7 in 2023

  • Americas market is expected to reach USD 6,316.4 by 2023


Key players for global nutrigenomics market:                                                      


Some of the major players in this market are: WellGen Inc. (US), Metagenics, Inc (US), Genomix Nutrition, Inc. (US), Nutrigenomix (US), NutraGene (India), XCODE Life Sciences Pvt. Ltd. (India), Cura Integrative Medicine (Australia)

The report for Global Nutrigenomics Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Scope of Study

2.2 Research Objective

2.3 Assumptions & Limitations

2.3.1 Assumptions

2.3.2 Limitations

2.4 Market Structure

3.1 Market Size Estimation

3.1.1 Market Share analysis

3.2 Market Pricing Approach

4.1 Drivers

4.1.1 Increased applications in dermatology

4.1.2 Increased applications in diagnosis of metabolic and genetic diseases

4.1.3 Increased application in food and beverages

4.1.4 Increased use in the diagnosis of bone diseases caused by Vitamin D metabolism

4.2 Restraints

4.2.1 High cost and time-consuming process

4.2.2 Need of well qualified physicians

4.2.3 Strict ethical implication

4.3 Opportunitie

4.3.1 Opportunities in the biomedical sciences

4.4 Threats

4.4.1 Misconception toward nutrigenomics

5.1 Porter’s five forces model

5.1.1 Bargaining power of suppliers

5.1.2 Bargaining power of buyers

5.1.3 Threat of New Entrant

5.1.4 Threat of substitute of services

5.1.5 Intensity of Rivalry

6.1 Introduction

6.2 Reagents & Kits

6.3 Services

8.1 Introduction

8.2 Obesity

8.3 Diabetes

8.4 Anti-aging

8.5 Chronic diseases

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 U.S

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K.

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.1.7 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Republic of Korea

9.4.5 Australia

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

10.1 WellGen Inc.

10.1.1 Company Overview

10.1.2 Product/Business Segment Overview

10.1.3 Key Development

10.1.4 SWOT Analysis

10.2 Metagenics, Inc

10.2.1 Company Overview

10.2.2 Product/Business Segment Overview

10.2.3 Key Development

10.2.4 SWOT Analysis

10.3 Genomix Nutrition, Inc.

10.3.1 Company Overview

10.3.2 Product/Business Segment Overview

10.3.3 Key Development

10.3.4 SWOT Analysis

10.4 Nutrigenomix

10.4.1 Company Overview

10.4.2 Product/Business Segment Overview

10.4.3 Key Development

10.4.4 SWOT Analysis

10.5 Cura Integrative Medicine

10.5.1 Company Overview

10.5.2 Product/Business Segment Overview

10.5.3 Key Development

10.5.4 SWOT Analysis

10.6 XCODE Life Sciences Pvt. Ltd.

10.6.1 Company Overview

10.6.2 Product/Business Segment Overview

10.6.3 Key Development

10.6.4 SWOT Analysis

10.7 NutraGene

10.7.1 Company Overview

10.7.2 Product/Business Segment Overview

10.7.3 Key Development

10.7.4 SWOT Analysis

TABLE 1 PRIMARY INTERVIEWS 16
TABLE 2 GLOBAL NUTRIGENOMICS MARKET, BY PRODUCTS 2014-2023 (USD MILLION) 25
TABLE 3 GLOBAL REAGENTS & KITS MARKET, BY REGION 2014-2023 (USD MILLION) 25
TABLE 4 GLOBAL SERVICES MARKET, BY REGION 2014-2023 (USD MILLION) 26
TABLE 5 GLOBAL NUTRIGENOMICS MARKET, TECHNIQUES, BY REGION, 2014-2023 (USD MILLION) 28
TABLE 6 GLOBAL SALIVA MARKET, BY REGION, 2014-2023 (USD MILLION) 28
TABLE 7 GLOBAL BUCCAL SWAB MARKET, BY REGION, 2014-2023 (USD MILLION) 29
TABLE 8 GLOBAL BLOOD MARKET, BY REGION, 2014-2023 (USD MILLION) 29
TABLE 9 GLOBAL NUTRIGENOMICS MARKET, BY APPLICATION 2014-2023 (USD MILLION) 31
TABLE 10 GLOBAL OBESITY MARKET, BY REGION 2014-2023 (USD MILLION) 32
TABLE 11 GLOBAL DIABETES MARKET, BY REGION 2014-2023 (USD MILLION) 33
TABLE 12 GLOBAL ANTI-AGING MARKET, BY REGION 2014-2023 (USD MILLION) 34
TABLE 13 GLOBAL CHRONIC DISEASES MARKET, BY REGION 2014-2023 (USD MILLION) 35
TABLE 14 GLOBAL NUTRIGENOMICS MARKET, BY REGION, 2014-2023 (USD MILLION) 37
TABLE 15 AMERICAS NUTRIGENOMICS MARKET, BY REGION, 2014-2023 (USD MILLION) 39
TABLE 16 AMERICAS NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 39
TABLE 17 AMERICAS NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 40
TABLE 18 AMERICAS NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 40
TABLE 19 NORTH AMERICA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 41
TABLE 20 NORTH AMERICA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 41
TABLE 21 NORTH AMERICA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 42
TABLE 22 U.S. NUTRIGENOMICS MARKET,BY TYPE, 2014-2023 (USD MILLION) 42
TABLE 23 U.S. NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 43
TABLE 24 U.S. NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 43
TABLE 25 CANADA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 44
TABLE 26 CANADA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 44
TABLE 27 CANADA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 45
TABLE 28 SOUTH AMERICA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 45
TABLE 29 SOUTH AMERICA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 46
TABLE 30 SOUTH AMERICA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 46
TABLE 31 EUROPE NUTRIGENOMICS MARKET, BY REGION, 2014-2023 (USD MILLION) 48
TABLE 32 EUROPE NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 48
TABLE 33 EUROPE NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 49
TABLE 34 EUROPE NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 49
TABLE 35 WESTERN EUROPE NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 50
TABLE 36 WESTERN EUROPE NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 50
TABLE 37 WESTERN EUROPE NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 51
TABLE 38 GERMANY NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 51
TABLE 39 GERMANY NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 52
TABLE 40 GERMANY NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 52
TABLE 41 FRANCE NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 53
TABLE 42 FRANCE NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 53
TABLE 43 FRANCE NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 54
TABLE 44 U.K. NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 54
TABLE 45 U.K. NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 55
TABLE 46 U.K. NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 55
TABLE 47 ITALY NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 56
TABLE 48 ITALY NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 56
TABLE 49 ITALY NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 57
TABLE 50 SPAIN NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 57
TABLE 51 SPAIN NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 58
TABLE 52 SPAIN NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 58
TABLE 53 REST OF WESTERN EUROPE NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 59
TABLE 54 REST OF WESTERN EUROPE NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 59
TABLE 55 REST OF WESTERN EUROPE NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 60
TABLE 56 EASTERN EUROPE NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 60
TABLE 57 EASTERN EUROPE NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 61
TABLE 58 EASTERN EUROPE NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 61
TABLE 59 ASIA-PACIFIC NUTRIGENOMICS MARKET, BY REGION, 2014-2023 (USD MILLION) 63
TABLE 60 ASIA-PACIFIC NUTRIGENOMICS MARKET, BY TYPES, 2014-2023 (USD MILLION) 63
TABLE 61 ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 64
TABLE 62 ASIA-PACIFIC NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 64
TABLE 63 JAPAN NUTRIGENOMICS MARKET, BY TYPES, 2014-2023 (USD MILLION) 65
TABLE 64 JAPAN NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 65
TABLE 65 JAPAN NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 66
TABLE 66 CHINA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 66
TABLE 67 CHINA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 67
TABLE 68 CHINA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 67
TABLE 69 INDIA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 68
TABLE 70 INDIA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 68
TABLE 71 INDIA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 69
TABLE 72 REPUBLIC OF KOREA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 69
TABLE 73 REPUBLIC OF KOREA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 70
TABLE 74 REPUBLIC OF KOREA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 70
TABLE 75 AUSTRALIA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 71
TABLE 76 AUSTRALIA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 71
TABLE 77 AUSTRALIA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 72
TABLE 78 REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 72
TABLE 79 REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 73
TABLE 80 REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 73
TABLE 81 MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET, BY REGION, 2014-2023 (USD MILLION) 74
TABLE 82 MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 75
TABLE 83 MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 75
TABLE 84 MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 76
TABLE 85 MIDDLE EAST NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 76
TABLE 86 MIDDLE EAST NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 77
TABLE 87 MIDDLE EAST NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 77
TABLE 88 AFRICA NUTRIGENOMICS MARKET, BY TYPE, 2014-2023 (USD MILLION) 78
TABLE 89 AFRICA NUTRIGENOMICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 78
TABLE 90 AFRICA NUTRIGENOMICS MARKET, BY TECHNIQUE, 2014-2023 (USD MILLION) 79
TABLE 91 METAGENICS, INC:KEY DEVELOPMENT 82
TABLE 92 GENOMIX NUTRITION, INC: KEY DEVELOPMENT 84
TABLE 93 NUTRIGENOMIX: KEY DEVELOPMENT 86
TABLE 94 CURA INTEGRATIVE MEDICINE, INC: KEY DEVELOPMENT 88
TABLE 95 XCODE LIFE SCIENCES PVT. LTD,: KEY DEVELOPMENT 90
TABLE 96 NUTRAGENE: KEY DEVELOPMENT 92

FIGURE 1 GLOBAL NUTRIGENOMICS MARKET SHARE, BY APPLICATION 2016 10
FIGURE 2 GLOBAL NUTRIGENOMICS MARKET SHARE, BY PRODUCTS 2016 11
FIGURE 3 GLOBAL NUTRIGENOMICS MARKET SHARE, BY REGIONS 2016 12
FIGURE 4 GLOBAL NUTRIGENOMICS: MARKET STRUCTURE 14
FIGURE 5 RESEARCH PROCESS 15
FIGURE 6 DRIVERS & RESTRAINTS IMPACT ANALYSIS OF GLOBAL NUTRIGENOMICS MARKET 18
FIGURE 7 PORTERS FIVE FORCES ANALYSISOF GLOBAL NUTRIGENOMICS MARKET 22
FIGURE 8 GLOBAL NUTRIGENOMICS MARKET SHARE, BY PRODUCT 2017 & 2023 (USD MILLION) 24
FIGURE 9 GLOBAL NUTRIGENOMICS MARKET SHARE, BY TECHNIQUES 2017 & 2023 (USD MILLION) 27
FIGURE 10 GLOBAL NUTRIGENOMICS MARKET SHARE, BY APPLICATION 2017 & 2023 (USD MILLION) 30
FIGURE 11 GLOBAL NUTRIGENOMICS MARKET SHARE, BY REGION 2017 & 2023 (USD MILLION) 36
FIGURE 12 AMERICAS NUTRIGENOMICS MARKET SHARE, BY REGION, 2016 38
FIGURE 13 EUROPE NUTRIGENOMICS MARKET SHARE, BY REGION 2016 47
FIGURE 14 ASIA PACIFIC NUTRIGENOMICS MARKET, BY COUNTRY 2016 62
FIGURE 15 MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SHARE, BY REGION 2016 74
FIGURE 16 WELLGEN, INC: SWOT ANALYSIS 81
FIGURE 17 GENOMIX NUTRITION, INC.: SWOT ANALYSIS 85
FIGURE 18 NUTRIGENOMIX: SWOT ANALYSIS 87
FIGURE 19 CURA INTEGRATIVE MEDICINE: SWOT ANALYSIS 89
FIGURE 20 XCODE LIFE SCIENCES PVT. LTD,:SWOT ANALYSIS 91
FIGURE 21 NUTRAGENE: SWOT ANALYSIS 93